03423220016
Sosyal Medya Hesaplarımız

Biosystems Control Serum CK-MB

Biosystems Control Serum CK-MB

Control Serum for MV of fraction of a kreatinkinaza is the lyophilized human serum containing the certain concentration of a kreatinkinaza of general (SK) and kreatinkinaza of MV of fraction (CK-MB) intended for quantitative quality control in clinical laboratories without which application changes of quality of tests are possible.

The product intends for control of accuracy and correctness of analytical methods.

 

STRUCTURE

Biosystems Control Serum CK-MB

CODE 18024 Control CK-MB serum of 1х0,5 ml. Human serum.

Components of a human origin were tested and presence of antibodies to anti-HIV and anti-HCV, and the HBs-anti-gen. is not found. However they can be potential carriers of an infection.

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING
Product: CREATINE KINASE-MB (CK-MB) STANDARD Component: S
Intended use: In vitro Diagnostic
Identification of the company:
BioSystems SA

2. HAZARDS IDENTIFICATION
Classification:
Pictogram: N/A
Signal word: N/A
Hazard statements: N/A
Precautionary statements: N/A
3. COMPOSITION/INFORMATION ON INGREDIENTS
4. FIRST AID MEASURES
5. FIRE-FIGHTING MEASURES
6. ACCIDENTAL RELEASE MEASURES
The substances are non-hazardous or in concentrations not to be declared.
Extinguishing media: No restriction.
Thermal decomposition: Gases which are damaging to health do not form in dangerous quantities.
Special measures to limit damage: Are not necessary.
Eye Contact: Wash eyes immediately with plenty of water.
Skin Contact: Wash with plenty of water.
Ingestion: Requires medical control.
After Spillage: Can be washed off with plenty of water.
Absorbent Material: Universal binder.
Not hazardous according to Regulation (EC) No. 1272/2008
Components from human origin have been tested and found to be negative for the presence of antibodies anti-HIV and anti-HCV as well as for HBs antigen. However the product should be handled cautiously as potentially infectious.
SAFETY DATA SHEET
(EC) 1907/2006 / (EU) 453/2010 / (EC) 1272/2008 (CLP)
CREATINE KINASE-MB (CK-MB) STANDARD S
06/03/2015 Pag.: 2
7. HANDLING AND STORAGE
Storage: 2-10º C

 

 

Brand: Biosystems